Veracyte Inc
NASDAQ:VCYT
Veracyte Inc
NASDAQ:VCYT
Price:
32.62
USD
12.95%
Market Closed
Market Cap:
2.5B
USD
Balance Sheet
Balance Sheet Decomposition
Veracyte Inc
Veracyte Inc
| Current Assets | 372.3m |
| Cash & Short-Term Investments | 289.4m |
| Receivables | 46.5m |
| Other Current Assets | 36.3m |
| Non-Current Assets | 927.8m |
| PP&E | 71.1m |
| Intangibles | 848.1m |
| Other Non-Current Assets | 8.5m |
Balance Sheet
Veracyte Inc
Veracyte Inc
Currency: USD
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
39
|
59
|
34
|
78
|
159
|
349
|
173
|
154
|
216
|
239
|
|
| Cash Equivalents |
39
|
59
|
34
|
78
|
159
|
349
|
173
|
154
|
216
|
239
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
0
|
50
|
|
| Total Receivables |
4
|
9
|
13
|
13
|
19
|
19
|
42
|
44
|
40
|
47
|
|
| Accounts Receivables |
4
|
9
|
13
|
13
|
19
|
19
|
42
|
44
|
40
|
47
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
4
|
4
|
5
|
3
|
7
|
5
|
11
|
14
|
16
|
22
|
|
| Other Current Assets |
2
|
2
|
2
|
2
|
2
|
3
|
17
|
12
|
13
|
15
|
|
| Total Current Assets |
48
|
74
|
54
|
97
|
188
|
376
|
243
|
249
|
286
|
372
|
|
| PP&E Net |
10
|
12
|
10
|
9
|
18
|
17
|
31
|
31
|
31
|
71
|
|
| PP&E Gross |
10
|
12
|
10
|
9
|
18
|
17
|
31
|
31
|
31
|
71
|
|
| Accumulated Depreciation |
5
|
7
|
9
|
12
|
14
|
16
|
22
|
26
|
33
|
39
|
|
| Intangible Assets |
15
|
14
|
13
|
12
|
65
|
60
|
203
|
175
|
89
|
102
|
|
| Goodwill |
1
|
1
|
1
|
1
|
3
|
3
|
708
|
696
|
703
|
746
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
2
|
2
|
2
|
3
|
6
|
7
|
9
|
|
| Other Assets |
1
|
1
|
1
|
1
|
3
|
3
|
708
|
696
|
703
|
746
|
|
| Total Assets |
75
N/A
|
101
+34%
|
79
-22%
|
121
+53%
|
275
+128%
|
457
+66%
|
1 188
+160%
|
1 156
-3%
|
1 115
-4%
|
1 300
+17%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5
|
2
|
4
|
3
|
2
|
3
|
12
|
12
|
13
|
9
|
|
| Accrued Liabilities |
9
|
9
|
8
|
9
|
15
|
13
|
43
|
42
|
44
|
51
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
8
|
9
|
5
|
19
|
|
| Total Current Liabilities |
15
|
12
|
12
|
13
|
18
|
17
|
64
|
63
|
61
|
79
|
|
| Long-Term Debt |
5
|
26
|
25
|
24
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
1
|
1
|
|
| Other Liabilities |
4
|
4
|
4
|
4
|
18
|
18
|
21
|
14
|
9
|
44
|
|
| Total Liabilities |
24
N/A
|
42
+73%
|
41
0%
|
41
-1%
|
36
-12%
|
36
+0%
|
91
+154%
|
81
-11%
|
71
-13%
|
124
+75%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
149
|
180
|
211
|
234
|
247
|
282
|
357
|
394
|
468
|
444
|
|
| Additional Paid In Capital |
200
|
240
|
248
|
314
|
486
|
703
|
1 469
|
1 500
|
1 536
|
1 656
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
15
|
31
|
24
|
36
|
|
| Total Equity |
51
N/A
|
60
+16%
|
37
-38%
|
80
+115%
|
240
+200%
|
421
+76%
|
1 097
+160%
|
1 075
-2%
|
1 044
-3%
|
1 176
+13%
|
|
| Total Liabilities & Equity |
75
N/A
|
101
+34%
|
79
-22%
|
121
+53%
|
275
+128%
|
457
+66%
|
1 188
+160%
|
1 156
-3%
|
1 115
-4%
|
1 300
+17%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
28
|
34
|
34
|
41
|
50
|
58
|
71
|
72
|
73
|
78
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
